Your browser doesn't support javascript.
loading
Genomics of therapy-related myeloid neoplasms.
Kuzmanovic, Teodora; Patel, Bhumika J; Sanikommu, Srinivasa R; Nagata, Yasunobu; Awada, Hassan; Kerr, Cassandra M; Przychodzen, Bartlomiej P; Jha, Babal K; Hiwase, Devendra; Singhal, Deepak; Advani, Anjali S; Nazha, Aziz; Gerds, Aaron T; Carraway, Hetty E; Sekeres, Mikkael A; Mukherjee, Sudipto; Maciejewski, Jaroslaw P; Radivoyevitch, Tomas.
Afiliación
  • Kuzmanovic T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Patel BJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Sanikommu SR; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Nagata Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Awada H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Kerr CM; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Przychodzen BP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Jha BK; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Hiwase D; Department of Haematology, Royal Adelaide Hospital, Port Road, Adelaide, Australia.
  • Singhal D; Department of Haematology, Royal Adelaide Hospital, Port Road, Adelaide, Australia.
  • Advani AS; Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Nazha A; Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Gerds AT; Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Carraway HE; Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Sekeres MA; Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Mukherjee S; Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA maciejj@ccf.org.
  • Radivoyevitch T; Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Haematologica ; 105(3): e98-e101, 2020 03.
Article en En | MEDLINE | ID: mdl-31413096
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasias Primarias Secundarias / Neoplasias Límite: Humans Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasias Primarias Secundarias / Neoplasias Límite: Humans Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos